890 studies found for: Open Studies | "Hypoglycemic Agents"
The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients
Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy
Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy
Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 Diabetes
|5||Not yet recruiting||
Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
Adipose Tissue Imaging in Type 2 Diabetes
Comparison Between Hypoglycemic Counter Regulatory Responses in Type 1 Diabetics vs Control Subjects
Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment
Glycemic Emergency Management (GEM); An App for Rapid Response to Hypoglycemic and Hyperglycemic Situations
Acute Kidney Injury in Patients on Dapagliflozin and Other Antidiabetic Medications
Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication.
Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea
CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea
|14||Not yet recruiting||
Effect of Anti-diabetic Drugs on Glycemic Variability
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
|16||Not yet recruiting||
Effects of Mild Hypoglycaemia on Cognitive Function in Type 2 Diabetes
Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes
Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"
ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon
† Study has passed its completion date and status has not been verified in more than two years.